Modulation of hyperglycemia and TNFα-mediated inflammation by helichrysum and grapefruit extracts in diabetic db/db

Ana Laura de la Garza1, Usune Etxeberria, Sara Palacios-Ortega

  • 1Department of Nutrition, Food Science and Physiology, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Navarra, Spain. jalfmtz@unav.es.

Food & Function
|July 9, 2014
PubMed

Insights

Helichrysum and grapefruit extracts effectively lowered blood sugar in diabetic mice by regulating liver glucose metabolism and reducing inflammation. These natural compounds may offer a new approach to managing type-2 diabetes and its associated inflammatory conditions.

Area of Science:

  • Metabolic disorders
  • Pharmacology
  • Immunology

Background:

  • Type-2 diabetes is linked to chronic inflammation and altered cytokine production from adipose tissue.
  • Flavonoids are being investigated for their potential antidiabetic properties, targeting mechanisms like insulin sensitization and glucose inhibition.
  • Obesity exacerbates inflammation, contributing to the complex pathophysiology of type-2 diabetes.

Purpose of the Study:

  • To evaluate the efficacy of helichrysum and grapefruit extracts in managing type-2 diabetes in a mouse model.
  • To investigate the molecular mechanisms underlying the antihyperglycemic and anti-inflammatory effects of these botanical extracts.
  • To explore the role of gene expression and DNA methylation in the therapeutic action of helichrysum and grapefruit.

Main Methods:

  • A study involving 36 diabetic male C57BL/6J db/db mice divided into control, acarbose, helichrysum, and grapefruit groups.
  • Administration of helichrysum (1 g/kg) and grapefruit (0.5 g/kg) extracts for 6 weeks, alongside a standard diet.
  • Analysis of mRNA expression in pancreas, liver, and adipose tissue using RT-PCR and quantification of DNA methylation in epididymal fat via pyrosequencing.

Main Results:

  • Helichrysum and grapefruit extracts significantly reduced fasting glucose levels (p < 0.05) and upregulated liver glucokinase.
  • A decrease in mRNA expression of proinflammatory genes (e.g., TNF-α, NF-κB) was observed in the liver and adipose tissue of treated mice.
  • Grapefruit extract notably increased DNA methylation at the TNFα CpG3 site in adipose tissue (p < 0.01), suggesting epigenetic modulation of inflammation.

Conclusions:

  • Helichrysum and grapefruit extracts demonstrate significant antihyperglycemic effects in type-2 diabetic mice.
  • These extracts modulate glucose metabolism and reduce inflammation by downregulating key proinflammatory genes in the liver and visceral fat.
  • Epigenetic modifications, such as TNFα hypermethylation, may play a role in the anti-inflammatory benefits of grapefruit extract in diabetes and obesity.

Related Concept Videos